synthesis-characterization-an-aspirin-fumarate-prodrug-that-inhibits

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells

Inflammation is a cancer hallmark that underlies cancer incidence and promotion, and eventually progression to metastasis. Therefore, adding an ...

University of Illinois at Chicago

Almost 70% of breast cancers are estrogen receptor α (ERα) positive. Tamoxifen, a selective estrogen receptor modulator (SERM), represents the standard of care for many patients; however, 30-50% develop resistance, underlining the need for alternative therapeutics. Paradoxically, agonists at ERα such as estradiol (E2) have demonstrated clinical efficacy in patients with heavily treated breast cancer, although side effects in gynecological tissues are unacceptable. A drug that selectively mimics the actions of E2 in breast cancer therapy but minimizes estrogenic effects in other tissues is a novel, therapeutic alternative. We hypothesized that a selective human estrogen receptor partial agonist (ShERPA) at ERα would provide such an agent. Novel benzothiophene derivatives with nanomolar potency in breast cancer cell cultures were designed. Several showed partial agonist activity, with potency of 0.8-76 nM, mimicking E2 in inhibiting growth of tamoxifen-resistant breast cancer cell lines. Three ShERPAs were tested and validated in xenograft models of endocrine-independent and tamoxifen-resistant breast cancer, and in contrast to E2, ShERPAs did not cause significant uterine growth.

Loruhama Delgado-Rivera

Medicinal Chemistry and Pharmacognosy,
College of Medicine,
Medicinal Chemistry and Pharmacognosy, College of Medicine

University of Illinois at Chicago

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Loruhama Delgado-Rivera

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Medicinal Chemistry and Pharmacognosy,College of Medicine,Medicinal Chemistry and Pharmacognosy, College of Medicine

University of Illinois at Chicago

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Medicinal Chemistry and Pharmacognosy,
College of Medicine,
Medicinal Chemistry and Pharmacognosy, College of Medicine